BioNTech

BioNTech reduces drug development spend as COVID-19 vaccine sales plunge

[ad_1] FRANKFURT: Germany’s BioNTech, Pfizer’s partner on COVID-19 vaccines, cut its drug development budget for this year after quarterly revenues…